pharmacy

Liv.52 was launched in 1955, and physicians worldwide recommend Liv.52 (tablet, syrup, and drops forms), for various hepatic disorders. Liv.52 is an extensively researched product of Himalaya Wellness Company. The potential hepatoprotective effect of Liv.52 has been established through numerous clinical studies, including randomized double blind, placebo controlled, open label studies, as well as independent investigator initiated clinical studies across many countries. The product has numerous research articles published in national and international scientific journals. Overall, the results derived from these research articles suggest that Liv.52 is beneficial for supportive treatment in improving the symptoms, hepatic parameters, and quality of life in a wide variety of liver diseases like drug-induced hepatotoxicity, hepatitis, alcoholic liver disease, and non-alcoholic fatty liver disease.